¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"active pyruvate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® chronic active hepatitis ÇÑ±Û ¸¸¼ºÈ°µ¿°£¿°
¼³¸í   
  BÇü °£¿°À̳ª ºñAÇü£­ºñBÇü °£¿°ÀÇ ¼Ó¹ßÁõÀ¸·Î ³ªÅ¸³ª´Â °£ÀÇ ¸¸¼º¿°ÁõÀÌ´Ù. °°Àº ÇüÅÂÀÇ º´ÀÌ ¼±Ãµ¼º ¶Ç´Â ÈÄõ°¨¸¶±Û·ÎºÒ¸°°áÇÌÁõÀ̳ª ¾î¶² Á¾·ùÀÇ ¾à¹° Åõ¿©¿¡ ¼ö¹ÝÇØ¼­ ³ªÅ¸³¯ ¼öµµ ÀÖ´Ù. Æ¯Â¡ÀûÀ¸·Î ¹®¸ÆºÎ¿¡ ÇüÁú¼¼Æ÷¿Í Å«Æ÷½Ä¼¼Æ÷ÀǠħÀ±, Á¶°¢±«»ç(°£¼Ò¿± ÁÖº¯ºÎ °£¼¼Æ÷ÀÇ ÆÄ±«) ¹× ¼¶À¯Áõ µîÀÇ Á¶Á÷¼Ò°ßÀ» ³ªÅ¸³½´Ù. º´ÀÇ °æ°ú´Â ¸Å¿ì ´Ù¾çÇϸç Àå±â°£ÀÇ ¹«Áõ»ó±â¸¦ º¸ÀÏ ¼öµµ ÀÖ°í ±× »çÀÌ »çÀÌ¿¡ È²´Þ, Àü½Å¼è¾à, ½Ä¿åºÎÁø ¹× ¹ß¿­ µîÀÇ Áõ»óÀÌ ³ªÅ¸³ª´Â ¼ö°¡ ÀÖÀ¸¸ç, ¶Ç ¹«¿ù°æÁõ, °üÀý¿°, ÇǺιßÁø, Ç÷°ü¿°, °©»ó»ù¿°, ÄáÆÏ»ç±¸Ã¼¿°, ±Ë¾ç¼º´ëÀå¿°, ½¦±×·»ÁõÈıº µî °£ ÀÌ¿ÜÀÇ Áõ»óÀÌ ³ªÅ¸³ª´Â ¼öµµ ÀÖ°í, °£°æÈ­Áõ°ú °£±â´É»ó½Ç·Î ÁøÇàµÇ´Â ¼öµµ ÀÖ´Ù. ÀÚ°¡¸é¿ª¸ÞÄ¿´ÏÁòÀÌ °ü¿©µÇ´Â °ÍÀ¸·Î ÃßÃøµÇ°í ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyruvate
    ÇÇ·çºê»ê¿°
  • pyruvate kinase
    ÇÇ·çºê»ê¿°Å°³ª¾ÆÁ¦
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª
  • active
    ´Éµ¿-, Àû±Ø-, Ȱ¼º-
  • active carbon
    Ȱ¼º½¡, Ȱ¼ºÅº
  • active electrode
    Ȱ¼ºÀü±Ø
  • active exercise
    ´Éµ¿¿îµ¿
  • active gradient shielding
    ´Éµ¿°æ»çÂ÷Æó
  • active hyperemia
    ´Éµ¿ÃæÇ÷
  • active imagination
    Àû±Ø»ó»ó, Àû±Ø¸í»ó
  • active immunity
    ´Éµ¿¸é¿ª
  • active immunization
    ´Éµ¿¸é¿ªÈ­
  • active incorporative mode
    Àû±ØÇÔÀÔ¾ç½Ä
  • active marrow
    Ȱ¼º°ñ¼ö
  • active material
    Ȱ¼º¹°Áú, Ȱ¼ºÀç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyruvate
    ÇÇ·çºê»ê¿°
  • active carbon
    Ȱ¼º½¡, Ȱ¼ºÅº
  • active immunity
    ´Éµ¿¸é¿ª
  • active material
    Ȱ¼º¹°Áú
  • active oxygen
    Ȱµ¿»ê¼Ò, Ȱ¼º»ê¼Ò
  • active phase
    Ȱ¼º±â
  • active site
    Ȱ¼ººÎÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyruvate kinase
    ÇÇ·çºó»ê¿°Å°³ª¾ÆÁ¦
  • pyruvate
    ÇÇ·çºê»ê¿°
  • active
    ´Éµ¿-, Àû±Ø-, Ȱ¼º-
  • active carbon
    Ȱ¼º½¡, Ȱ¼ºÅº
  • active electrode
    Ȱµ¿Àü±Ø
  • active exercise
    ´Éµ¿¿îµ¿
  • active hydrogen
    Ȱ¼º¼ö¼Ò
  • active hyperemia
    ´Éµ¿ÃæÇ÷
  • active imagination
    Àû±Ø»ó»ó, Àû±Ø¸í»ó
  • active immunity
    ´Éµ¿¸é¿ª
  • active immunization
    ´Éµ¿¸é¿ªÈ­
  • active marrow
    Ȱ¼º°ñ¼ö
  • active material
    Ȱ¼º¹°Áú
  • active movement
    ´Éµ¿¿îµ¿
  • active negativism
    Àû±Ø°ÅºÎÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • GPT => glutamic pyruvate transaminase
    ±Û·çŽÇÇ·çºó»êÆ®¶õ½º¾Æ¹Ì³ªÁ¦
  • glutamate pyruvate transaminase
    ±Û·çŽÇÇ·çºó»êÆ®¶õ½º¾Æ¹Ì³ªÁ¦
  • pyruvate
    ÇÇ·çºê»ê¿°
  • pyruvate kinase
    ÇÇ·çºê»ê¿° Ű³ªÁ¦
  • pyruvate pathway
    ÇÇ·çºê»ê¿°´ë»ç°æ·Î(¡­ß«ç¤ÓÛÞóÌèÖØ).
  • MR active element
    ÀÚ±â°ø¸í Ȱ¼º ¿ä¼Ò
  • MR active nuclei
    ÀÚ±â°ø¸í Ȱ¼º ÇÙ
  • active
    Ȱµ¿¼º(üÀÔÑàõ), ´Éµ¿¼º(ÒöÔÑàõ).
  • active hyperemia
    ´Éµ¿Àû Ç÷·ùÁõ°¡(ÒöÔÑîÜúì×µñòÊ¥)
  • active apperception
    ÀÚµ¿(Àû)Åë°¢(ÀÛ¿ë)(í»ÔÑîÜ÷ÖÊÆíÂéÄ).
  • active carbon
    Ȱ¼ºÅº(üÀàõ÷©).
  • active earth
    Ȱ¼ºÅä(Ì·ËÛ̬).
  • active exercise
    ÀÚµ¿¿îµ¿(í»ÔÑê¡ÔÑ).
  • active exercise
    ÀÚµ¿¿îµ¿(í»ÔÑê¡ÔÑ).
  • active force generation test
    ±Ù·Â°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glutamate pyruvate transaminase
    ±Û·çŽÇÇ·çºó»êÆ®¶õ½º¾Æ¹Ì³ªÁ¦
  • pyruvate
    ÇÇ·çºê»ê¿°
  • pyruvate kinase
    ÇÇ·çºê»ê¿° Ű³ªÁ¦
  • pyruvate pathway
    ÇÇ·çºê»ê¿°´ë»ç°æ·Î(¡­ß«ç¤ÓÛÞóÌèÖØ).
  • active
    Ȱµ¿¼º(üÀÔÑàõ), ´Éµ¿¼º(ÒöÔÑàõ).
  • active hyperemia
    ´Éµ¿Àû Ç÷·ùÁõ°¡(ÒöÔÑîÜúì×µñòÊ¥)
  • active apperception
    ÀÚµ¿(Àû)Åë°¢(ÀÛ¿ë)(í»ÔÑîÜ÷ÖÊÆíÂéÄ).
  • active carbon
    Ȱ¼ºÅº(üÀàõ÷©).
  • active earth
    Ȱ¼ºÅä(Ì·ËÛ̬).
  • active exercise
    ÀÚµ¿¿îµ¿(í»ÔÑê¡ÔÑ).
  • active exercise
    ÀÚµ¿¿îµ¿(í»ÔÑê¡ÔÑ).
  • active force generation test
    ±Ù·Â°Ë»ç
  • active glycine
    Ȱ¼º(üÀàõ)±Û¸®½Å.
  • active gradient shielding
    ´Éµ¿ °æ»ç Â÷Æó
  • active hydrogen
    Ȱ¼º¼ö¼Ò(¡­â©áÈ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • active pyruvate
    Ȱ¼º(üÀàõ)ÆÄÀÌ·çºê»ê¿° (ß«ç¤)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • citrate-pyruvate cycle
    ½ÃÆ®¸£»ê(ß«)-ÇǸ£ºê»êȸ·Î(ß«üÞÖØ)
  • pyruvate carboxylase
    ÆÄÀÌ·çºê»ê(ß«) Ä«¸£º¹½Ç·¹À̽º
  • pyruvate dehydrogenase complex
    ÆÄÀÌ·çºê»ê(ß«) µðÇÏÀ̵å·ÎÀú³×À̽º º¹ÇÕü(ÜÜùêô÷)
  • pyruvate kinase
    ÆÄÀÌ·çºê»ê(ß«) Ä«À̳×À̽º
  • pyruvate oxidation factor
    ÆÄÀÌ·çºê»ê(ß«) »êÈ­ÀÎÀÚ(ß«ûùì×í­)
  • active acetaldehyde
    Ȱ¼º(üÀàõ) ¾Æ¼¼Æ®¾Ëµ¥ÇÏÀ̵å
  • active acetate
    Ȱ¼º¾Æ¼¼Æ®»ê¿°(ß«ç¤)
  • active acetyl
    Ȱ¼º(üÀàõ)¾Æ¼¼Æ¿
  • active acyl
    Ȱ¼º (üÀàõ)¾Æ½Ç
  • active adenocyl
    Ȱ¼º(üÀàõ) ¾Æµ¥³ë½Ç
  • active adenylate
    Ȱ¼º ¾Æµ¥´Ò»ê¿° (ß«ç¤)
  • active aldehyde
    Ȱ¼º(üÀàõ)¾Ëµ¥ÇÏÀ̵å
  • active aldehyde theory
    Ȱ¼º(üÀàõ)¾Ëµ¥ÇÏÀ̵å·Ð(Öå)
  • active amino acid
    Ȱ¼º(üÀàõ)¾Æ¹Ì³ë»ê (ß«)
  • active anaphylaxis
    Ȱ¼º(üÀàõ)¾Æ³ªÇʶô½Ã½º
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • active
    Ȱµ¿¼º, ´Éµ¿¼º
  • active gradient shielding
    ´Éµ¿°æ»çÂ÷Æó
  • active shielding
    ´Éµ¿Â÷Æó
  • active shimming
    ´Éµ¿º¸Á¤
  • MR active element
    ÀÚ±â°ø¸íȰ¼º¿ä¼Ò
  • MR active nuclei
    ÀÚ±â°ø¸íȰ¼ºÇÙ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AA abdominal aorta; acetic acid; achievement age; active alcoholic; active assistive [range of motion];...
PDHa pyruvate dehydrogenase in active form
AAROM active assertive range of motion; active-assisted range of motion
AS acetylstrophanthidin; acidified serum; acoustic schwannoma; acoustic stimulation; active sarcoidosis...
PC   1) Phosphatidyl Choline
  2) Pyruvate Carboxylase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HPPD 4-hydroxyphenyl pyruvate dioxygenase
GPT Glutamate pyruvate transaminase
GPT Glutamic-pyruvate transaminase
LPK L Pyruvate kinase
P L)-pyruvate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • active
    Ȱ¼º, Ȱµ¿¼º, ´Éµ¿¼º
    ÀÛ¿ë, Ȱµ¿, ÇàÀ§¸¦ Ư¡À¸·Î Çϸç, ¼öµ¿ÀûÀÌ ¾Æ´Ñ °Í.
  • active acupuncture locus
    Ȱµ¿¼º °æÇ÷ Á¡
  • active coefficient
    Ȱ¼ºµµ °è¼ö
    ¹°ÁúÀÇ ³óµµ°¡ ³·À» ¶§¿¡ ¹ÝÀÀ·ÂÀº ³óµµ¿¡ ºñ·ÊÇϴµ¥ ³óµµ°¡ ³ô¾ÆÁ³À» ¶§´Â ¹ÝÀÀ·ÂÀÌ °¨¼ÒµÇ°í, ³óµµ¿¡ Ȱµ¿°è¼ö¸¦ °öÇÑ °Í¿¡ ºñ·ÊÇØ¼­ ¹ÝÀÀ·ÂÀÌ ³ªÅ¸³­´Ù.
  • active eruption
    Ȱ¼º ¸ÍÃâ, ´Éµ¿Àû ¸ÍÃâ
    1. ¸Å¸ôµÇ¾î ÀÖ´ø Ä¡¾Æ°¡ »ý¸®ÀûÀ¸·Î ´ëÇÕÄ¡ÀÇ ±³ÇÕ¸é±îÁö ¸ÍÃâÇϰųª ¸ÍÃâµÈ Ä¡¾Æ°¡ ¸¶¸ðµÈ °í°æ¸¸Å­ º¸»óÇϱâ À§ÇØ ¸ÍÃâÇÏ´Â Çö»ó. 2. Ä¡¾Æ°¡ ±³ÇÕÁ¢ÃËÀ» ÀÌ·é ÈÄ, ±³ÇÕÆò¸é ¹æÇâÀ¸·Î ´Éµ¿Àû À̵¿À» º¸ÀÌ´Â °Í.
  • active exercise program
    Àû±ØÀû ¿îµ¿
  • active gradient shielding
    ´Éµ¿ °æ»çÂ÷Æó
  • active hydrogen
    Ȱ¼º ¼ö¼Ò
  • active immunity
    ´Éµ¿ ¸é¿ª
    Ç׿ø Àڱؿ¡ ¹ÝÀÀÇÏ¿© »ý»êµÈ Ç×ü³ª ¸é¿ª ¸²ÇÁ°è ¼¼Æ÷ÀÇ Á¸Àç·Î ÀÎÇÑ È¹µæ¸é¿ª. »ç¶÷¿¡ ´ëÇØ¼­ ¹é½ÅÀ̳ª µ¶¼ºÀ¸·Î ¸é¿ªÇÏ´Â °ÍÀ¸·Î ÀÚ½ÅÀÇ ¸öÀ¸·Î ¸é¿ªÀ» ¸¸µé¾î³»¹Ç·Î È¿°ú´Â ¿À·¡ Áö¼ÓµÈ´Ù.
  • active mandibular opening
    ´Éµ¿ ÇÏ¾Ç °³±¸
    ±æÇ×±Ù
  • active material
    Ȱ¼º ¹°Áú
    È­ÇÐ ¹ÝÀÀ¿¡ À־ Ã˸ÅÀÇ ¹ÝÀÀ ÃËÁø ´É·ÂÀ» Ȱ¼ºÈ­ ½ÃŰ´Â ¹°Áú.
  • active myofascial trigger point
    Ȱµ¿¼º ±Ù¸· ¹ßÅëÁ¡
    ÃËÁøÀ» ÅëÇØ ÀÚ±ØÀ» ÁÖÁö ¾Ê´õ¶óµµ ±¹¼ÒÀûÀ̰ųª ÀüÀÌµÈ ÅëÁõÀ̳ª Áõ»óÀ» ³ªÅ¸³»´Â ±Ù¸· ¹ßÅëÁ¡.
  • active principle
    À¯È¿¼ººÐ
    ¾à¹°ÀÇ È¿°ú¸¦ ºÎ¿©ÇÏ´Â ¾à¹° ÁßÀÇ ¼ººÐ
  • active relaxation therapy
    ´Éµ¿ ÀÌ¿Ï ¿ä¹ý
  • active sensitization
    ´Éµ¿ °¨ÀÛ, ´Éµ¿Àû °¨ÀÛ
    »ýü¿¡ Ç׿øÀ» ÁÖ»çÇÑ °á°ú ³ªÅ¸³ª´Â ¿¹¹Î¼º.
  • active shimming
    ´Éµ¿ º¸Á¤
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
active pyruvate An intermediate formed in the oxidative decarboxylation of pyruvate.
Compare: pyruvate dehydrogenase (lipoamide).
Synonym: alpha-lactyl-thiamin pyrophosphate.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
beta-alanine-pyruvate aminotransferase <enzyme> An enzyme that reversibly transfers the amino group of beta-alanine to paruvate, thus producing l-alanine and malonate saemialdehyde. A deficiency of this enzyme is believed to be the cause of hyper-beta-alaninaemia.
(05 Mar 2000)
beta-aminoisobutyrate:pyruvate aminotransferase Beta-aminosiobutyrate:pyruvate transaminase;an enzyme that catalyses the reversible transfer of an amino group from beta-aminoisobutyrate to pyruvate, producing l-alanine and methylmalonate saemialdehyde. A step in valine degradation. A deficiency of beta-aminoisobutyrate:pyruvate aminotransferase results in hyper-beta-aminoisobutyric aciduria.
(05 Mar 2000)
valine-pyruvate transaminase <enzyme> E coli enzyme catalyzing the terminal step of valine biosynthesis; consider also EC 2.6.1.42, branched-chain-amino-acid transaminase; alanine-alpha-oxoisovalerate aminotransferase and alanine-alpha-ketoisovalerate aminotransferase were ens to alanine aminotransferase 1981-93
Registry number: EC 2.6.1.66
Synonym: alanine-valine transaminase, transaminase c, alanine alpha-ketoisovalerate aminotransferase, alanine-alpha-oxoisovalerate aminotransferase, alanine-alpha-ketoisovalerate aminotransferase
(26 Jun 1999)
glutamine-pyruvate aminotransferase <enzyme> Consider also glutamine transaminase k if cysteine conjugate beta-lyase activity is also present; l-methionine can act as donor; glyoxylate can act as acceptor
Registry number: EC 2.6.1.15
Synonym: glutamine alpha-ketoacid transaminase, glutamine transaminase, glutamine transaminase l, glutamine oxo-acid aminotransferase, glutaminase II, glutamine aminotransferase, l-methionine aminotransferase
(26 Jun 1999)
chorismate pyruvate-lyase <enzyme> Forms 4-hydroxybenzoic acid for ubiquinone biosynthesis; chorismate pyruvate-lyase (amino-accepting) is anthranilate synthase
Registry number: EC 4.1.3.-
Synonym: ubic gene product, chorismate lyase
(26 Jun 1999)
serine-pyruvate aminotransferase <enzyme> Do not confuse with alanine-glyoxylate aminotransferase (EC 2.6.1.44), even though they may be products of the same gene; index whichever is discussed or both
Registry number: EC 2.6.1.51
Synonym: serine aminotransferase, serine-pyruvate transaminase
(26 Jun 1999)
pyruvate <biochemistry> Pyruvate is the final product of glycolysis. You get two molecules of pyruvate for every molecule of glucose that goes through glycolysis.
(22 Aug 1998)
pyruvate carboxylase <enzyme> An enzyme that catalyses the formation of oxaloacetate from pyruvate, carbon dioxide and ATP in gluconeogenesis.
(18 Nov 1997)
pyruvate carboxylase deficiency An autosomal recessive pyruvate metabolism disorder resulting from absent or deficient expression of pyruvate carboxylase activity. Decreased production of oxaloacetate leads to decreased gluconeogenesis, thereby causing fasting hypoglycaemia, lactic acid acidosis, and decreased synthesis of amino acid neurotransmitters. Clinical presentations include acidosis, ataxia, mental retardation; sometimes co-occurs with leigh disease.
(12 Dec 1998)
pyruvate decarboxylase <enzyme> Catalyses the decarboxylation of an alpha keto acid to an aldehyde and carbon dioxide. Thiamine pyrophosphate is an essential cofactor. In lower organisms, which ferment glucose to ethanol and carbon dioxide, the enzyme irreversibly decarboxylates pyruvate to acetaldehyde.
Registry number: EC 4.1.1.1
(12 Dec 1998)
pyruvate dehydrogenase <enzyme> A complex multienzyme system that catalyses the conversion of (pyruvate + CoA + NAD) to (acetyl CoA + CO2 + NAD).
(18 Nov 1997)
pyruvate dehydrogenase complex <enzyme> A complex multienzyme system that catalyses the conversion of (pyruvate + CoA + NAD) to (acetyl CoA + CO2 + NAD).
(18 Nov 1997)
pyruvate dehydrogenase complex deficiency An autosomal recessive pyruvate metabolism disorder resulting from deficient enzyme activity in one of several proteins of pyruvate dehydrogenase complex, resulting in deficiency of acetyl CoA. Deficiency in acetyl CoA product reduces the synthesis of acetylcholine, thereby causing neurological abnormalities. Clinical presentations include lactic acidosis, mental retardation, and ataxia.
(12 Dec 1998)
pyruvate dehydrogenase complex inactivase <enzyme> Pharmacological action: enzyme inhibitor
Registry number: EC 3.4.-
(26 Jun 1999)
pyruvate dehydrogenase (cytochrome) An oxidoreductase catalyzing reaction between ferricytochrome b1 and pyruvate to yield acetate and CO2, and ferrocytochrome b1.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • active
    Ȱµ¿ÀûÀÎ
  • active
    Ȱµ¿ÀûÀÎ;Àû±ØÀûÀÎ;Èû¼¾;´Éµ¿ÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á